<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR10">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>He</surname>
    <given-names>MM</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Jin</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>SQ</given-names>
   </name>
   <name>
    <surname>Ren</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>HY</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>ZQ</given-names>
   </name>
   <name>
    <surname>Qiu</surname>
    <given-names>MZ</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>ZX</given-names>
   </name>
   <name>
    <surname>Zeng</surname>
    <given-names>ZL</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel in untreated patients with metastatic gastric cancer</article-title>
  <source>Cancer Sci</source>
  <year>2018</year>
  <volume>109</volume>
  <issue>11</issue>
  <fpage>3575</fpage>
  <lpage>3582</lpage>
  <pub-id pub-id-type="doi">10.1111/cas.13813</pub-id>
  <pub-id pub-id-type="pmid">30281875</pub-id>
 </element-citation>
</ref>
